株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の皮下ドラッグデリバリー市場:規模、シェア、動向、および予測

Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability, by Disease Indication, by Delivery Type, by Distribution Channel and by Region - Size, Share, Trends, and Forecast 2018 - 2026

発行 Coherent Market Insights 商品コード 906232
出版日 ページ情報 英文 237 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
世界の皮下ドラッグデリバリー市場:規模、シェア、動向、および予測 Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability, by Disease Indication, by Delivery Type, by Distribution Channel and by Region - Size, Share, Trends, and Forecast 2018 - 2026
出版日: 2019年07月30日 ページ情報: 英文 237 Pages
概要

当レポートは世界の皮下ドラッグデリバリー市場について調査しており、市場の機会や動向、成長および阻害要因、有用性・疾患適応症・投与タイプ・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の目的および仮定

  • 調査目的
  • 仮定
  • 略語

第2章 市場の範囲

  • レポートの説明
    • 市場の定義および範囲
  • エグゼクティブサマリー
    • 有用性別
    • 疾患適応症別
    • 投与タイプ別
    • 流通チャネル別
    • 地域別
  • COM (Coherent Opportunity Map)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発
  • 規制シナリオ
  • 償還シナリオ
  • 合併および買収のシナリオ
  • PEST分析
  • 疫学

第4章 皮下ドラッグデリバリーの世界市場:有用性別

  • イントロダクション
  • 使い捨て
  • 再利用可能

第5章 皮下ドラッグデリバリーの世界市場:疾患適応症別

  • イントロダクション
  • 自己免疫疾患
  • 神経学的障害
  • 腫瘍疾患
  • ホルモン障害
  • アレルギーおよび感染症
  • 眼疾患
  • その他

第6章 皮下ドラッグデリバリーの世界市場:投与タイプ別

  • イントロダクション
  • プレフィルドシリンジ
  • 注射
  • プレフィルドペン
  • バイアル(シリンジ)
  • ポンプおよびその他

第7章 皮下ドラッグデリバリーの世界市場:流通チャネル別

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第8章 皮下ドラッグデリバリーの世界市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋地域
  • 中東
  • アフリカ

第9章 競合情勢

  • ヒートマップ分析
  • 市場シェア分析
    • Becton Dickinson and Company*
    • Novo Nordisk A/S
    • Johnson & Johnson
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • F. Hoffmann-La Roche AG
    • Consort Medical plc
    • Eli Lilly and Company
    • Merck & Co., Inc.
  • アナリストの見解

第10章 セクション

  • 参照資料
  • 調査方法
  • Coherent Market Insightについて
目次

Title:
Subcutaneous Drug Delivery Market - Global Forecast to 2026, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Injector, Prefilled Pen, Vial (Syringe), Pump, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

The market comprises of products, which are available in reusable and disposable form. Disposable segment is expected to witness growth, owing to significant increase in self-administration of drugs to treat chronic diseases. Moreover, the shift from vial-and-syringe format, which is prone to dosing errors and low patient-compliance rates to prefilled syringes that enable the use of disposable and single-use syringes already filled with a prescribed unit dose of medication, is expected to enhance the market growth.

Market Dynamics:

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe in 2017, without tungsten to create perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal. However, higher cost of auto-injectors and product recalls are factors expected to restrain the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2018-2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global subcutaneous drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

  • Global Subcutaneous Drug Delivery Market, By Usability:
    • Disposable
    • Reusable
  • Global Subcutaneous Drug Delivery Market, By Disease Indication:
    • Auto-immune Disorders
    • Neurological Disorders
    • Oncology Disorders
    • Hormonal Disorders
    • Allergy & Infectious Disorders
    • Ophthalmic Disorders
    • Others
  • Global Subcutaneous Drug Delivery Market, By Delivery Type:
    • Prefilled Syringe
    • Injector
    • Prefilled Pen
    • Vial (Syringe)
    • Pump and Others
  • Global Subcutaneous Drug Delivery Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Subcutaneous Drug Delivery Market, By Region:
    • North America
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Usability:
      • Disposable
      • Reusable
      • By Disease Indication:
      • Auto-immune Disorders
      • Neurological Disorders
      • Oncology Disorders
      • Hormonal Disorders
      • Allergy & Infectious Disorders
      • Ophthalmic Disorders
      • Others
      • By Delivery Type:
      • Prefilled Syringe
      • Injector
      • Prefilled Pen
      • Vial (Syringe)
      • Pump and Others
      • By Distribution Channel:
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novo Nordisk A/S
    • Johnson & Johnson
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen, Inc.
    • F. Hoffmann-La Roche AG
    • Consort Medical plc
    • Eli Lilly and Company
    • Merck & Co., Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Usability
    • Market Snippet, By Disease Indication
    • Market Snippet, By Delivery Type
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Reimbursement Scenario
  • Merger and Acquisition Scenario
  • PEST Analysis
  • Epidemiology

4. Global Subcutaneous Drug Delivery Market, By Usability, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

5. Global Subcutaneous Drug Delivery Market, By Disease Indication, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Auto-immune Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Oncology Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Hormonal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Allergy & Infectious Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Ophthalmic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

6. Global Subcutaneous Drug Delivery Market, By Delivery System, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Prefilled Syringe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Injector
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Prefilled Pen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Vial (Syringe)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Pump and Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

7. Global Subcutaneous Drug Delivery Market, By Distribution Channel, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Mn)

8. Global Subcutaneous Drug Delivery Market, By Region, 2016 - 2026, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2016 and 2026 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Usability, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Disease Indication, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Delivery System, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Becton Dickinson and Company*
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novo Nordisk A/S
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi S.A.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Amgen, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Consort Medical plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top